About Anthony Zietman, MD

Dr Zietman received his undergraduate training at Oxford University in the UK and then went to medical school at the Middlesex Hospital, London University graduating in 1983. After residencies in internal medicine and clinical oncology he moved to the Massachusetts General Hospital in Boston, USA for a fellowship in radiation biology. Since joining the staff he has authored over 100 original articles and reviews on many aspects of GU cancer. His particular research interests are in the specific roles of active surveillance, brachytherapy, hormone therapy, and proton beam therapy in the treatment of prostate cancer. He also has a long-standing interest in the organ-sparing management of bladder cancer. He is currently the Jenot and William Shipley Professor of Radiation Oncology at Harvard Medical School, President of the American Society for Radiation Oncology (ASTRO), and a trustee of the American Board of Radiology.

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Languages:

Locations

Genitourinary Cancer Center
55 Fruit Street
Boston, MA 02114
617-726-5866
Fax: 617-643-1740

Clark Center for Radiation Oncology
100 Blossom Street
Boston, MA 02114-2606

Medical Education

  • MD, University of London
  • Residency, Massachusetts General Hospital
  • Residency, Westminster Hospital
  • Fellowship, Massachusetts General Hospital
  • Fellowship, Middlesex Hospital

American Board Certifications

  • Radiation Oncology, American Board of Radiology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Publications

  • Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Barry MJ, Zietman A.L., O'Leary M, Walker-Corkery E, Yao SL. Outcomes of localized prostate cancer following conservative management. JAMA 16:302 1202-9 2009

    Zietman A.L., Bae K., Slater J.D., Shipley W.U., Efstathiou J.A., Coen J.J., Bush D.A., Lunt M., Spiegel D.Y., Skowronski R., Jabola B.R., Rossi C.J. A randomized trial comparing conventional dose conformal radiation therapy with high-dose in early stage adenocarcinoma of the prostate. Long-term results from Proton Radiaiton Oncology Group (PROG)/American College of Radiology (ACR) 95-09. J. Clin. Oncol. (in press) 2009.

    Zietman A.L.. The Titanic and The Iceberg: prostate proton therapy and healthcare economics. J. Clin. Oncol. 25: 3565-66, 2007.

    Zietman A.L.. Evidence-based medicine, conscience-based medicine, and the management of low-risk prostate cancer.J. Clin Oncol. 27:4935-6, 2009